TEAS RF New Application

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1478 (Rev 09/2006)

OMB No. 0651-0009 (Exp 02/28/2021)

---

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1478 (Rev 09/2006)

OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 88443951

Filing Date: 05/23/2019

To the Commissioner for Trademarks:

MARK: CUANDO EL DOLOR SE VA, VUELVE LA VIDA (Standard Characters, see mark)
The literal element of the mark consists of CUANDO EL DOLOR SE VA, VUELVE LA VIDA.
The mark consists of standard characters, without claim to any particular font style, size, or color.

The applicant, GlaxoSmithKline Consumer Healthcare (UK) IP Limited, a limited liability company legally organized under the laws of England, having an address of
      980 Great West Road
      Brentford, Middlesex TW89GS
      United Kingdom
      XXXX (not authorized)

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

For specific filing basis information for each item, you must view the display within the Input Table.
       International Class 005:  Analgesic preparations

In International Class 005, the mark was first used by the applicant or the applicant's related company or licensee or predecessor in interest at least as early as 05/31/2014, and first used in commerce at least as early as 05/31/2014, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in the class of listed goods/services, consisting of a(n) Display in the shape of a cart. Slogan is on the bottom of display.
Specimen File1


Translation
The English translation of CUANDO EL DOLOR SE VA, VUELVE LA VIDA in the mark is When Pain is Gone, Life Returns.

The applicant's current Attorney Information:
      Terence A. Dixon and Christopher M Hanes and Merilee Arevalo of GSK
      LBP - NY0300
      5 Cresent Drive
      Philadelphia, Pennsylvania 19112
      United States
      484-885-9127(phone)
      trademarks@gsk.com (authorized)
The attorney docket/reference number is 82777888.

The applicant's current Correspondence Information:

Terence A. Dixon

GSK

LBP - NY0300       5 Cresent Drive

Philadelphia, Pennsylvania 19112

484-885-9127(phone)

trademarks@gsk.com (authorized) E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at the e-mail address provided in this application. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional processing fee of $125 per international class of goods/services.

A fee payment in the amount of $275 has been submitted with the application, representing payment for 1 class(es).

Declaration

	Basis: If the applicant is filing the application based on use in commerce under 15 U.S.C. § 1051(a): The signatory believes that the applicant is the owner of the trademark/service mark sought to be registered; The mark is in use in commerce on or in connection with the goods/services in the application; The specimen(s) shows the mark as used on or in connection with the goods/services in the application; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate. And/Or If the applicant is filing the application based on an intent to use the mark in commerce under 15 U.S.C. § 1051(b), § 1126(d), and/or § 1126(e): The signatory believes that the applicant is entitled to use the mark in commerce; The applicant has a bona fide intention to use the mark in commerce on or in connection with the goods/services in the application; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate.
	To the best of the signatory's knowledge and belief, no other persons, except, if applicable, concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services of such other persons, to cause confusion or mistake, or to deceive.
	To the best of the signatory's knowledge, information, and belief, formed after an inquiry reasonable under the circumstances, the allegations and other factual contentions made above have evidentiary support.
	The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. § 1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any registration resulting therefrom, declares that all statements made of his/her own knowledge are true and all statements made on information and belief are believed to be true.

Declaration Signature

Signature: /tad/   Date: 05/23/2019
Signatory's Name: Terence A. Dixon
Signatory's Position: Trademark Counsel, PA bar member
Payment Sale Number: 88443951
Payment Accounting Date: 05/24/2019

Serial Number: 88443951
Internet Transmission Date: Thu May 23 16:12:57 EDT 2019
TEAS Stamp: USPTO/BAS-XXX.XX.XX.X-201905231612574873
27-88443951-620943ff2cd47c7218e933ab93c9
1ad0f278cd76fdcc4b4dc0d4a05a568a405ebf-D
A-2890-20190523135639031979